Inhibiting C-Jun to Retard Cell Proliferation Promoted by AP-2β in the Breast Cancer

Benyu Yang

2022

Abstract

AP-2 is a molecular marker in breast cancer cells without too much attention before. A tight association between AP-2 overexpression and breast cancer was reported. This study investigates whether c-jun is the certain down-stream protein of AP-2 in regulating the cell proliferation in breast cancer. The expression of AP-2 in human cell line will be measure by Western Blot. Tumor size in vivo will be measured by volume. The possible results include: the tumor growth of positive control is slower than negative control group, the tumor is increasingly faster growing compared with negative control, or the tumor is growing in the same speed in both negative and positive control groups. The result will indicate whether C-jun is a key downstream target for mediating the tumor-promoting role of AP-2.

Paper Citation

in Harvard Style

Yang B. (2022). Inhibiting C-Jun to Retard Cell Proliferation Promoted by AP-2β in the Breast Cancer. In Proceedings of the 1st International Conference on Health Big Data and Intelligent Healthcare - Volume 1: ICHIH, ISBN 978-989-758-596-8, pages 302-307. DOI: 10.5220/0011361100003438

in Bibtex Style

@conference{ichih22,
author={Benyu Yang},
title={Inhibiting C-Jun to Retard Cell Proliferation Promoted by AP-2β in the Breast Cancer},
booktitle={Proceedings of the 1st International Conference on Health Big Data and Intelligent Healthcare - Volume 1: ICHIH,},
year={2022},
pages={302-307},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0011361100003438},
isbn={978-989-758-596-8},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 1st International Conference on Health Big Data and Intelligent Healthcare - Volume 1: ICHIH,
TI - Inhibiting C-Jun to Retard Cell Proliferation Promoted by AP-2β in the Breast Cancer
SN - 978-989-758-596-8
AU - Yang B.
PY - 2022
SP - 302
EP - 307
DO - 10.5220/0011361100003438